Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Sato

Showing results (471-480 of 514) with videos related to

Pageof 52
Sort By:
International Journal of Molecular Sciences|May 14, 2025
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver CirrhosisTakuya Matsuda, Tadashi Namisaki, Akihiko Shibamoto, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 13, 2022
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosisTadashi Namisaki, Kosuke Kaji, Naotaka Shimozato, et al.
Scientific Reports|January 27, 2021
Clonal hematopoiesis in adult pure red cell aplasiaNaohito Fujishima, Junki Kohmaru, Souichi Koyota, et al.
Gynecologic Oncology|July 21, 2023
Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology GroupAkira Kikuchi, Hiroshi Yoshida, Hitoshi Tsuda, et al.
Cancer Science|September 17, 2020
No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of NagasakiEo Toriyama, Tomoko Hata, Ken-Ichi Yokota, et al.
Haematologica|May 19, 2019
Genome analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMasataka Taguchi, Hiroyuki Mishima, Yusuke Shiozawa, et al.
Digestive Diseases and Sciences|March 12, 2025
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular CarcinomaYuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, et al.
Plos One|November 19, 2016
A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control StudyHidenori Sato, Yoshimi Takahashi, Luna Kimihira, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2019
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosisNaotaka Shimozato, Tadashi Namisaki, Kosuke Kaji, et al.
Oncology Letters|September 21, 2017
Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolizationAkitoshi Douhara, Tadashi Namisaki, Kei Moriya, et al.
Pageof 52

Showing results (471-480 of 514) with videos related to

Sort By:
Pageof 52
International Journal of Molecular Sciences|May 14, 2025
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver CirrhosisTakuya Matsuda, Tadashi Namisaki, Akihiko Shibamoto, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 13, 2022
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosisTadashi Namisaki, Kosuke Kaji, Naotaka Shimozato, et al.
Scientific Reports|January 27, 2021
Clonal hematopoiesis in adult pure red cell aplasiaNaohito Fujishima, Junki Kohmaru, Souichi Koyota, et al.
Gynecologic Oncology|July 21, 2023
Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology GroupAkira Kikuchi, Hiroshi Yoshida, Hitoshi Tsuda, et al.
Cancer Science|September 17, 2020
No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of NagasakiEo Toriyama, Tomoko Hata, Ken-Ichi Yokota, et al.
Haematologica|May 19, 2019
Genome analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMasataka Taguchi, Hiroyuki Mishima, Yusuke Shiozawa, et al.
Digestive Diseases and Sciences|March 12, 2025
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular CarcinomaYuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, et al.
Plos One|November 19, 2016
A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control StudyHidenori Sato, Yoshimi Takahashi, Luna Kimihira, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2019
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosisNaotaka Shimozato, Tadashi Namisaki, Kosuke Kaji, et al.
Oncology Letters|September 21, 2017
Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolizationAkitoshi Douhara, Tadashi Namisaki, Kei Moriya, et al.
Pageof 52